Skip to search formSkip to main contentSkip to account menu

ID Rhabdomyosarcoma Regimen

Known as: ID Regimen, IRS-IV ID Regimen, Ifosfamide-Doxorubicin Rhabdomyosarcoma Regimen 
A regimen consisting of ifosfamide and doxorubicin used for the treatment of high-risk childhood rhabdomyosarcoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.